These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 38283929)
1. The ins and outs of lipoprotein(a) assay methods. Heydari M; Rezayi M; Ruscica M; Jpamialahamdi T; Johnston TP; Sahebkar A Arch Med Sci Atheroscler Dis; 2023; 8():e128-e139. PubMed ID: 38283929 [TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Current Understanding and Future Perspectives. Wu MF; Xu KZ; Guo YG; Yu J; Wu Y; Lin LM Cardiovasc Drugs Ther; 2019 Dec; 33(6):739-748. PubMed ID: 31655942 [TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462 [TBL] [Abstract][Full Text] [Related]
4. High lipoprotein(a) levels and small apolipoprotein(a) size prospectively predict cardiovascular events in dialysis patients. Longenecker JC; Klag MJ; Marcovina SM; Liu YM; Jaar BG; Powe NR; Fink NE; Levey AS; Coresh J J Am Soc Nephrol; 2005 Jun; 16(6):1794-802. PubMed ID: 15800123 [TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) - Marker for cardiovascular risk and target for lipoprotein apheresis. Klingel R; Heigl F; Schettler V; Roeseler E; Grützmacher P; Hohenstein B; Vogt A; Fassbender C; Heibges A; Julius U Atheroscler Suppl; 2019 Dec; 40():17-22. PubMed ID: 31818445 [TBL] [Abstract][Full Text] [Related]
6. Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations. Ward NC; Watts GF; Bishop W; Colquhoun D; Hamilton-Craig C; Hare DL; Kangaharan N; Kostner KM; Kritharides L; O'Brien R; Mori TA; Nestel PJ; Nicholls SJ; Psaltis PJ; Raffoul N; White HD; Sullivan DR Heart Lung Circ; 2023 Mar; 32(3):287-296. PubMed ID: 36707360 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. Lampsas S; Xenou M; Oikonomou E; Pantelidis P; Lysandrou A; Sarantos S; Goliopoulou A; Kalogeras K; Tsigkou V; Kalpis A; Paschou SA; Theofilis P; Vavuranakis M; Tousoulis D; Siasos G Molecules; 2023 Jan; 28(3):. PubMed ID: 36770634 [TBL] [Abstract][Full Text] [Related]
8. To test, or not to test: that is the question for the future of lipoprotein(a). Ellis KL; Chakraborty A; Moses EK; Watts GF Expert Rev Cardiovasc Ther; 2019 Apr; 17(4):241-250. PubMed ID: 30916582 [TBL] [Abstract][Full Text] [Related]
9. Burden of lipoprotein(a) for patients with atherosclerotic cardiovascular disease: A retrospective analysis from the United States. Fonseca AF; Byrne H; Laguna A; Itani T; Studer R; Heo J; Dillon A; Ferber P; Costa-Scharplatz M J Manag Care Spec Pharm; 2023 May; 29(5):519-529. PubMed ID: 37121256 [No Abstract] [Full Text] [Related]
10. Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease. Boffa MB; Koschinsky ML Nat Rev Cardiol; 2019 May; 16(5):305-318. PubMed ID: 30675027 [TBL] [Abstract][Full Text] [Related]
11. Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies. Alhomoud IS; Talasaz A; Mehta A; Kelly MS; Sisson EM; Bucheit JD; Brown R; Dixon DL Pharmacotherapy; 2023 Oct; 43(10):1051-1063. PubMed ID: 37464942 [TBL] [Abstract][Full Text] [Related]
12. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers? Koschinsky ML Cardiovasc Hematol Disord Drug Targets; 2006 Dec; 6(4):267-78. PubMed ID: 17378772 [TBL] [Abstract][Full Text] [Related]
13. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members. Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142 [TBL] [Abstract][Full Text] [Related]
14. Treatment of Lp(a): Is It the Future or Are We Ready Today? Tselepis AD Curr Atheroscler Rep; 2023 Oct; 25(10):679-689. PubMed ID: 37668953 [TBL] [Abstract][Full Text] [Related]